Christopher Moore
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 4
- Ion channel regulation and function 3
- Receptor Mechanisms and Signaling 2
- Physiology 11
- Nitric Oxide and Endothelin Effects 3
- Pain Mechanisms and Treatments 3
- Voice and Speech Disorders 3
- Co-authors
- Julian Downward (12 shared papers)Sareena Rana (10 shared papers)Míriam Molina‐Arcas (9 shared papers)Bradley Spencer‐Dene (3 shared papers)Philip East (4 shared papers)Emma Nye (2 shared papers)Davide Zecchin (2 shared papers)Sophie de Carné Trécesson (3 shared papers)
- Journals
- Cancer Research (3 papers)Nature Communications (3 papers)British Journal of Pharmacology (2 papers)Journal of Thrombosis and Haemostasis (2 papers)Cancer Cell (2 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Christopher Moore
50 papers receiving 2.1k citations
Christopher Moore's Hit Papers
Peers
Comparison fields: 5 of 118
- Oncology 549
- Immunology 440
- Hepatology 102
- Molecular Biology 874
- Cancer Research 144
Countries citing papers authored by Christopher Moore
This map shows the geographic impact of Christopher Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Moore more than expected).
Fields of papers citing papers by Christopher Moore
This network shows the impact of papers produced by Christopher Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Moore. The network helps show where Christopher Moore may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Moore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA Hit paper breakdown → | 2017 | 495 |
| 2 | 2005 | 191 | |
| 3 | 2019 | 154 | |
| 4 | 2013 | 143 | |
| 5 | 2013 | 126 | |
| 6 | 2019 | 92 | |
| 7 | 2022 | 79 | |
| 8 | 2010 | 53 | |
| 9 | 2022 | 53 | |
| 10 | 2021 | 47 | |
| 11 | 2019 | 46 | |
| 12 | 2009 | 45 | |
| 13 | 1986 | 45 | |
| 14 | 2021 | 42 | |
| 15 | 1991 | 41 | |
| 16 | 2000 | 40 | |
| 17 | 2008 | 39 | |
| 18 | 2020 | 38 | |
| 19 | 1988 | 33 | |
| 20 | 1995 | 32 |
About Christopher Moore
Christopher Moore is a scholar working on Molecular Biology, Physiology, Oncology, Cellular and Molecular Neuroscience and Pulmonary and Respiratory Medicine, having authored 53 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Nitric Oxide and Endothelin Effects (3 papers), Pain Mechanisms and Treatments (3 papers), Voice and Speech Disorders (3 papers), Ion channel regulation and function (3 papers), Neuroendocrine regulation and behavior (2 papers) and Receptor Mechanisms and Signaling (2 papers). The work is most often cited by research in Oncology (549 citations), Immunology (440 citations), Hepatology (102 citations), Molecular Biology (874 citations) and Cancer Research (144 citations). Christopher Moore has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Julian Downward, Sareena Rana, Míriam Molina‐Arcas, Bradley Spencer‐Dene, Philip East, Emma Nye, Davide Zecchin, Sophie de Carné Trécesson, Ambrosius P. Snijders and Perry J. Blackshear. Their work appears in journals such as Cancer Research, Nature Communications, British Journal of Pharmacology, Journal of Thrombosis and Haemostasis and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.